Skip to main content
. 2019 Oct 18;12(12):1566–1573. doi: 10.1016/j.tranon.2019.08.011

Figure 4.

Figure 4

The CRISPR-Cas12a system for detecting HPV DNA in clinical plasma specimens.

Using CRISPR-Cas12a-paper to detect HPV DNA in plasma of 15 cervical cancer patients (A) and 14 cancer-free female individuals without any cancer (B). Black cells indicate positive HPV16 results, while gray cells indicate positive HPV18 results in plasma.